Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-04-19 Sale | 2024-04-23 6:38 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 64,653 | $14.12 | $913,057 | 3,437,322 (Indirect) | View |
2024-04-16 Sale | 2024-04-18 5:10 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 16,992 | $14.02 | $238,231 | 3,501,975 (Indirect) | View |
2024-04-11 Sale | 2024-04-15 5:25 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 485,000 | $14.49 | $7,026,033 | 3,518,967 (Indirect) | View |
2024-02-02 Sale | 2024-02-06 7:16 pm | NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer | 17,589 | $15.09 | $265,401 | 77,762 (Direct) | View |
2024-01-30 Sale | 2024-02-01 9:47 pm | NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer | 13,848 | $15.09 | $208,965 | 95,351 (Direct) | View |
2024-01-24 Sale | 2024-01-26 6:04 pm | NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer | 828 | $15.02 | $12,441 | 109,199 (Direct) | View |
2023-12-26 Sale | 2023-12-28 5:47 pm | NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer | 13,402 | $10.12 | $135,668 | 110,027 (Direct) | View |
2023-12-20 Sale | 2023-12-22 4:21 pm | NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer | 2,730 | $10.14 | $27,695 | 123,429 (Direct) | View |
2023-12-06 Sale | 2023-12-07 4:07 pm | NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer | 11,005 | $8.1575 | $89,773 | 126,159 (Direct) | View |
2023-11-29 Sale | 2023-12-01 9:57 pm | NeuroPace Inc | NPCE | KCK LTD. 10% Owner | 16,167 | $8.7761 | $141,882 | 5,593,773 (Direct) | View |
2023-11-27 Sale | 2023-11-29 5:35 pm | NeuroPace Inc | NPCE | KCK LTD. 10% Owner | 11,171 | $8.872 | $99,109 | 5,609,940 (Direct) | View |
2023-10-02 Sale | 2023-10-04 5:36 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 8,314 | $9.0749 | $75,449 | 4,003,967 (Indirect) | View |
2022-11-21 Purchase | 2022-11-23 5:29 pm | NeuroPace Inc | NPCE | Accelmed Partners II L.P. 10% Owner | 390,291 | $1.499 | $585,046 | 4,432,948 (Direct) | View |
2022-06-08 Sale | 2022-06-09 7:47 pm | NeuroPace Inc | NPCE | Ridley Irina General Counsel and Secretary | 2,500 | $5.778 | $14,445 | 61,139 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-27 Option Award | 2024-02-28 8:56 pm | N/A 2034-02-26 | NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer | 37,450 | $0 | 115,212 (Direct) | View |
2024-02-27 Option Award | 2024-02-28 8:54 pm | N/A 2034-02-26 | NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer | 37,450 | $0 | 177,154 (Direct) | View |
2024-02-27 Option Award | 2024-02-28 8:52 pm | N/A 2034-02-26 | NeuroPace Inc | NPCE | Becker Joel Chief Executive Officer | 157,190 | $0 | 157,190 (Direct) | View |
2023-07-18 Option Award | 2023-07-19 4:47 pm | N/A 2033-07-17 | NeuroPace Inc | NPCE | Becker Joel Chief Executive Officer | 380,424 | $0 | 380,424 (Direct) | View |
2023-06-07 Option Award | 2023-06-14 5:00 pm | N/A 2033-06-06 | NeuroPace Inc | NPCE | Andrade Lisa Director | 27,380 | $0 | 27,380 (Direct) | View |
2023-06-07 Option Award | 2023-06-14 4:59 pm | N/A 2033-06-06 | NeuroPace Inc | NPCE | Fischer Frank M Director | 27,380 | $0 | 27,380 (Direct) | View |
2023-06-07 Option Award | 2023-06-14 4:58 pm | N/A 2033-06-06 | NeuroPace Inc | NPCE | Geiger Uri Director | 27,380 | $0 | 27,380 (Direct) | View |
2023-06-07 Option Award | 2023-06-14 4:56 pm | N/A 2033-06-06 | NeuroPace Inc | NPCE | Kumar Rakhi Director | 27,380 | $0 | 27,380 (Direct) | View |
2023-06-07 Option Award | 2023-06-14 4:54 pm | N/A 2033-06-06 | NeuroPace Inc | NPCE | LACOB JOSEPH Director | 27,380 | $0 | 27,380 (Direct) | View |
2023-06-07 Option Award | 2023-06-14 4:53 pm | N/A 2033-06-06 | NeuroPace Inc | NPCE | Ryan Renee Director | 27,380 | $0 | 27,380 (Direct) | View |
2023-02-20 Option Award | 2023-02-22 7:54 pm | N/A N/A | NeuroPace Inc | NPCE | Ridley Irina Chief Legal Officer/Secretary | 80,000 | $0 | 141,139 (Direct) | View |
2023-02-20 Option Award | 2023-02-22 7:53 pm | N/A N/A | NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer | 80,000 | $0 | 139,704 (Direct) | View |
2023-02-20 Option Award | 2023-02-22 7:39 pm | N/A N/A | NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer | 80,000 | $0 | 137,164 (Direct) | View |
2023-02-21 Option Award | 2023-02-22 7:38 pm | N/A N/A | NeuroPace Inc | NPCE | Favet Michael Chief Executive Officer | 225,000 | $0 | 407,080 (Direct) | View |
2023-01-05 Option Award | 2023-01-09 4:30 pm | N/A 2033-01-04 | NeuroPace Inc | NPCE | Geiger Uri Director | 120,521 | $0 | 120,521 (Direct) | View |
Ownership | 2023-01-09 4:28 pm | N/A N/A | NeuroPace Inc | NPCE | Geiger Uri Director | 0 | $0 | 4,432,948 (Indirect) | View |
2022-10-31 Exercise | 2022-11-02 9:18 pm | N/A 2022-11-12 | NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer | 1,428 | $0 | 59,704 (Direct) | View |
2022-10-31 Exercise | 2022-11-02 9:18 pm | N/A N/A | NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer | 1,428 | $0.026 | 59,704 (Direct) | View |
2022-10-18 Exercise | 2022-10-20 7:57 pm | N/A 2022-11-12 | NeuroPace Inc | NPCE | LACOB JOSEPH Director | 192 | $0 | 352,112 (Direct) | View |
2022-10-18 Exercise | 2022-10-20 7:57 pm | N/A N/A | NeuroPace Inc | NPCE | LACOB JOSEPH Director | 192 | $0.026 | 352,112 (Direct) | View |
2022-10-07 Exercise | 2022-10-11 4:09 pm | N/A 2022-11-13 | NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer | 576 | $0 | 57,164 (Direct) | View |
2022-10-07 Exercise | 2022-10-11 4:09 pm | N/A N/A | NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer | 576 | $0.026 | 57,164 (Direct) | View |
2022-06-13 Option Award | 2022-06-21 9:13 pm | N/A 2032-06-12 | NeuroPace Inc | NPCE | Andrade Lisa Director | 18,253 | $0 | 18,253 (Direct) | View |
2022-06-13 Option Award | 2022-06-21 9:12 pm | N/A 2032-06-12 | NeuroPace Inc | NPCE | Fischer Frank M Director | 18,253 | $0 | 18,253 (Direct) | View |
2022-06-13 Option Award | 2022-06-21 9:12 pm | N/A 2032-06-12 | NeuroPace Inc | NPCE | Garfield Greg Shaw Director | 18,253 | $0 | 18,253 (Direct) | View |
2022-06-13 Option Award | 2022-06-21 9:11 pm | N/A 2032-06-12 | NeuroPace Inc | NPCE | Kumar Rakhi Director | 18,253 | $0 | 18,253 (Direct) | View |
2022-06-13 Option Award | 2022-06-21 9:10 pm | N/A 2032-06-12 | NeuroPace Inc | NPCE | LACOB JOSEPH Director | 18,253 | $0 | 18,253 (Direct) | View |
2022-06-13 Option Award | 2022-06-21 9:09 pm | N/A 2032-06-12 | NeuroPace Inc | NPCE | Ryan Renee Director | 18,253 | $0 | 18,253 (Direct) | View |